Warnings about the risk of ketoacidosis and serious urinary tract infections have been added to the labels of SGLT2 inhibitors.
Katie Eder, Senior Editor, Pharmacy Times
Advertisement
Articles by Katie Eder, Senior Editor, Pharmacy Times
Advertisement
Latest Updated Articles
Diabetes Drug Label Includes New RisksPublished: December 8th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Recognizing Immunizing Pharmacists in the Community
2
PCV20 Demonstrates Real-World Effectiveness Against Pneumonia in Older Adults
3
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
4
FDA Grants Interchangeability Designation to Denosumab Biosimilars Stoboclo and Osenvelt
5
